Advertisement

Topics

MANGANESE SULFATE INJECTION, USP | Manganese Sulfate [American Regent, Inc.] | BioPortfolio

15:46 EST 26th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Rx Only

STERILE, NONPYROGENIC, TRACE ELEMENT ADDITIVE FOR IV USE AFTER DILUTION (MANGANESE 0.1 mg/mL) PRESERVATIVE FREE

Manganese Sulfate Injection, USP is a sterile, nonpyrogenic solution intended for use as an additive to solutions for Total Parenteral Nutrition (TPN). Each mL contains 0.308 mg of Manganese Sulfate Monohydrate, USP, Water for Injection q.s. pH adjusted with Sulfuric Acid. It delivers elemental manganese 0.1 mg/mL. It is a single dose preservative free vial. Discard any unused portion.

Manganese is an activator for enzymes such as polysaccharide polymerase, liver arginase, cholinesterase and pyruvate carboxylase. Providing manganese during TPN prevents development of the following deficiency symptoms: nausea and vomiting, weight loss, dermatitis and changes in growth and color of hair.

Manganese Sulfate Injection, USP is indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

Manganese Sulfate Injection, USP should not be given undiluted by direct injection into a peripheral vein because of the potential for infusion phlebitis.

This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.

Manganese is eliminated via the bile. The possibility of manganese retention should be considered in patients with biliary tract obstruction. Decreasing or omitting manganese supplements entirely may be necessary for such patients. However, ancillary routes of manganese excretion include pancreatic juice, or reabsorption into the lumen of the duodenum, jejunum or ileum.

Safety for use in pregnancy has not been established. Use of manganese in women of childbearing potential requires that anticipated benefits be weighed against possible hazards.

Adverse reactions to manganese at the dosage levels recommended have not been reported.

Manganese Sulfate Injection, USP provides 0.1 mg manganese/mL. For the metabolically stable adult receiving TPN, the suggested additive dosage level for manganese is 0.15 to 0.8 mg/day. For pediatric patients, a dosage level of 2 to 10 mcg manganese/kg/day is recommended.

Aseptic addition of Manganese Sulfate Injection, USP to the TPN solution under a laminar flow hood is recommended. Manganese is physically compatible with the electrolytes and vitamins usually present in the amino acid/dextrose solution used for TPN. Periodic monitoring of manganese plasma levels is suggested as a guideline for subsequent administration.

Parenteral drug products should be inspected visually for particulate matter and discoloration, whenever solution and container permit.

Manganese toxicity has not been reported in patients receiving TPN. Neither have reports of manganese toxicity from excessive intake in foods and/or beverages been published.

Manganese Sulfate Injection, USP 0.1 mg/mL

NDC 0517-6410-25                                 10 mL SDV                        packed in a box of 25

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) (See USP Controlled Room Temperature).

IN6410

Rev. 1/09

MG #14479

AMERICAN REGENT, INC. SHIRLEY, NY 11967

NDC 0517-6410-25

MANGANESE SULFATE INJECTION, USP

Manganese 1 mg/10 mL

(0.1 mg/mL)

10 mL SINGLE DOSE VIAL

Trace Element Additive

FOR IV USE AFTER DILUTION

PRESERVATIVE FREE

Rx Only

AMERICANREGENT, INC.SHIRLEY, NY 11967

NDC 0517-6410-2525 x 10 mLSINGLE DOSE VIALS MANGANESE SULFATE INJECTION, USP

Manganese 1 mg/10 mL(0.1 mg/mL)

10 mL SINGLE DOSE VIAL

Trace Element Additive

FOR IV USE AFTER DILUTION.  PRESERVATIVE FREE            Rx Only

Each mL contains: Manganese Sulfate (Monohydrate) 0.308 mg, Water for Injection q.s.pH adjusted with Sulfuric Acid. Sterile, nonpyrogenic. WARNING: DISCARD UNUSED PORTION. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) (See USP Controlled Room Temperature). Directions for Use: See Package Insert.

AMERICAN REGENT, INC.SHIRLEY, NY 11967 Iss. 12/16

Manufacturer

American Regent, Inc.

Active Ingredients

Source

Drugs and Medications [67 Associated Drugs and Medications listed on BioPortfolio]

Centratex [centurion labs]

Centratex Capsules

Manganese [hospira, inc.]

Manganese0.1 mg/mL

Multitrace -4 pediatric [american regent, inc.]

MULTITRACE - 4 PEDIATRIC (TRACE ELEMENTS INJECTION 4, USP)

Multitrace-4 [american regent, inc.]

MULTITRACE -4 (TRACE ELEMENTS INJECTION 4, USP)

Trace elements 4 [american regent, inc.]

TRACE ELEMENTS INJECTION 4, USP

Clinical Trials [853 Associated Clinical Trials listed on BioPortfolio]

Manganese in Women With Encephalopathy

Objective: Report manganese serum levels and mortality in encephalopathic patients. Patients and participants: Consecutive patients aged > 18 years, with hepatic encephalopathy an...

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

To determine the clinical efficacy of indinavir sulfate or placebo in combination with zidovudine ( AZT ) and lamivudine ( 3TC ) in AIDS patients. Protease inhibitors such as indinavir su...

A Study of Intravenous Isavuconazonium Sulfate in Pediatric Patients

The purpose of the study is to evaluate the pharmacokinetics (PK), safety and tolerability of multiple doses of intravenous (IV) isavuconazonium sulfate administered daily in pediatric pat...

Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial

All women with severe preeclmapsia were given a loading dose of 4 g magnesium sulfate IV followed by the maintenance dose of 1 g/h infusion till the delivery. After delivery, women who rec...

Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions

Determine the pharmacokinetics and optimize study design for subsequent studies with morphine sulfate tablets and solution.

PubMed Articles [1113 Associated PubMed Articles listed on BioPortfolio]

Calcium ameliorates the toxicity of sulfate salinity in Brassica rapa.

Salinity stress in Brassica, often only associated with osmotic effects and the toxicity of Na, was more severe when applied as NaSO than as NaCl, indicating that SO ions had toxic effects as well. Ap...

Room-temperature synthesis of OMS-2 hybrids as highly efficient catalysts for pollutant degradation via peroxymonosulfate activation.

Due to low cost and low toxicity, manganese oxides have been extensively explored to reduce organic pollutants in wastewater via peroxymonosulfate (PMS) activation; but the development of manganese-ba...

Enhanced electrokinetic remediation of manganese and ammonia nitrogen from electrolytic manganese residue using pulsed electric field in different enhancement agents.

Electrolytic manganese residue (EMR) is a solid waste generated in the process of producing electrolytic metal manganese and contains a lot of manganese and ammonia nitrogen. In this study, electrokin...

How manganese empowered life with dioxygen (and vice versa).

Throughout the history of life on Earth, abiotic components of the environment have shaped the evolution of life, and in turn life has shaped the environment. The element manganese embodies a special ...

New Insights into the Combination of Permanganate and Bisulfite as a Novel Advanced Oxidation Process: Importance of High Valent Manganese-Oxo Species and Sulfate Radical.

Recently, it has been reported that the combination of permanganate (Mn(VII)) and bisulfite can lead to a rapid degradation of organic contaminants, where soluble Mn(III) is proposed to be responsible...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record